TOKYO, April 24 (Reuters) - Japan’s Takeda Pharmaceutical Co Ltd plans to sell its consumer health unit for around 400 billion yen ($3.72 billion), Nikkei Business reported.
Possible buyers of the unit include Taisho Pharmaceutical Co. and large investment funds, Nikkei reported. A Takeda spokeswoman said the company does not comment on rumours.
Following its acquisition of Shire Plc in 2019 for $59 billion, Takeda has pledged to dispose of $10 billion worth of non-core assets to pare down debt. ($1 = 107.6500 yen) (Reporting by Rocky Swift; Editing by Muralikumar Anantharaman)